Ember LifeSciences, Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-03-03.
Ember LifeSciences, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on March 3, 2026. The filing reports $32.17M sold. Its industry group is Other Technology. It names Timothy White (Director), Clayton Alexander (Executive Officer, Director), Ann Hyllengren (Executive Officer) (SEC Form D/A, March 3, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Ember LifeSciences, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-03 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Ember LifeSciences, Inc.
Free to see. No signup.
More on the people and the money behind Ember LifeSciences, Inc., from the filings we hold.
Other Technology raises by companies based in California, filed in March 2026, largest first.
Get an email when Ember LifeSciences, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Ember LifeSciences, Inc. raises, hires or launches. No email unless you switch it on.
Watch Ember LifeSciences, Inc. →Get the full cited report on Ember LifeSciences, Inc.
What the filing shows about Ember LifeSciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Ember LifeSciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Ember LifeSciences, Inc.'s address as 31416 Agoura Rd., Suite 225, Westlake Village, CA 91361.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Ember LifeSciences, Inc. →
Amended on 2026-08-20: the amount sold changed from $20,941,497 to $32,166,448; the number of investors changed from 38 to 50. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Ember LifeSciences, Inc. See pricing
Ember LifeSciences, Inc. is a registered filer with the SEC (CIK 2110315) and has filed since 2026-03-03. 1 filing is on record, the latest on 2026-03-03.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Ember LifeSciences, Inc.'s Form D of 2026-03-03 names Timothy White, Clayton Alexander, Ann Hyllengren and 3 more as its officers, directors or promoters.
Its new offerings report $20.94M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 3844 filings in Other Technology, totalled by week. The dot is this raise, $32.17M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Ember LifeSciences is revolutionizing the cold chain with the Ember Cube, providing sustainable cold chain solutions for drug delivery. Our cloud-based, self-refrigerated shipping technology ensures the integrity and efficacy of life-saving medicines while reducing waste.
The title and description the site itself served, answering 200, after redirecting from https://emberlifesciences.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Timothy White is named as Director on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
Clayton Alexander is named as Executive Officer and Director on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
Ann Hyllengren is named as Executive Officer on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
Brian Bejarano is named as Executive Officer on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
Michael Kaufmann is named as Director on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
James DeNaut is named as Director on the Form D that Ember LifeSciences, Inc. filed with the SEC on 3 March 2026, one of 6 people that filing names.
6 people named on the filing — 3 holding an executive role and 3 as directors only.
Named as of the 2026-03-03 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Ember LifeSciences, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Ember LifeSciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Ember LifeSciences, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Ember LifeSciences, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Ember LifeSciences, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (emberlifesciences.com).
Each opens in a new tab, filled in for Ember LifeSciences, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Los Angeles
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/ember-lifesciences-inc-form-d-26000001